Literature DB >> 25468047

Risk factors for adverse fetal outcomes among women with early- versus late-onset intrahepatic cholestasis of pregnancy.

Jin Jin1, Shi-lei Pan2, Li-ping Huang1, Yan-hong Yu1, Mei Zhong1, Guo-wei Zhang3.   

Abstract

OBJECTIVE: To determine risk factors for adverse fetal outcomes (AFOs) among women with intrahepatic cholestasis of pregnancy (ICP) on the basis of time of onset.
METHODS: In a retrospective analysis, data were obtained for all women with ICP admitted to two centers in Guangzhou, China, between February 1, 1993, and January 31, 2014. Patients were divided into group A (early-onset ICP) and group B (late-onset ICP), and were further divided on the basis of severity. The frequency of AFOs was assessed.
RESULTS: Among 371 eligible women, 57 (15.4%) were in group A and 314 (84.6%) in group B. AFOs affected 20 (35.1%) women in group A and 67 (21.3%) in group B (P=0.024), and 12 (54.5%) of 22 women in group A and 21 (29.6%) of 71 in group B with severe ICP (P=0.032). Independent risk factors for AFO in group A were increased levels of serum bile acid (P=0.016) and alkaline phosphatase (P=0.004). Independent risk factors in group B were increased levels of alkaline phosphatase (P<0.001) and gamma-glutamyl transpeptidase (P=0.001).
CONCLUSION: Early-onset ICP is associated with a higher frequency of AFO than is late-onset ICP, especially in severe disease. The risk factors differ between early-onset and late-onset ICP.
Copyright © 2014 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Adverse fetal outcomes; Intrahepatic cholestasis of pregnancy; Risk factor

Mesh:

Substances:

Year:  2014        PMID: 25468047     DOI: 10.1016/j.ijgo.2014.09.013

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  7 in total

Review 1.  [Intrahepatic cholestasis of pregnancy : Rare but important].

Authors:  A E Kremer; K Wolf; S Ständer
Journal:  Hautarzt       Date:  2017-02       Impact factor: 0.751

2.  Predictors of adverse neonatal outcomes in intrahepatic cholestasis of pregnancy.

Authors:  Tetsuya Kawakita; Laura I Parikh; Patrick S Ramsey; Chun-Chih Huang; Alexander Zeymo; Miguel Fernandez; Samuel Smith; Sara N Iqbal
Journal:  Am J Obstet Gynecol       Date:  2015-06-10       Impact factor: 8.661

3.  Impacts of different methods of conception on the perinatal outcome of intrahepatic cholestasis of pregnancy in twin pregnancies.

Authors:  Chun Feng; Wen-Juan Li; Rong-Huan He; Xi-Wen Sun; Guirong Wang; Li-Quan Wang
Journal:  Sci Rep       Date:  2018-03-05       Impact factor: 4.379

4.  Effect of Intrahepatic Cholestasis of Pregnancy on Neonatal Birth Weight: A Meta-Analysis.

Authors:  Li Li; Yuan Hua Chen; Yuan Yuan Yang; Lin Cong
Journal:  J Clin Res Pediatr Endocrinol       Date:  2017-08-21

Review 5.  Stillbirth and associated perinatal outcomes in obstetric cholestasis: a systematic review and meta-analysis of observational studies.

Authors:  Manoj Mohan; Antoniou Antonios; Justin Konje; Stephen Lindow; Mohamed Ahmed Syed; Anthony Akobeng
Journal:  Eur J Obstet Gynecol Reprod Biol X       Date:  2019-05-02

6.  Women successfully treated for severe intrahepatic cholestasis of pregnancy do not have increased risks for adverse perinatal outcomes.

Authors:  Jielian Yang; Chong Chen; Min Liu; Shuye Zhang
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

7.  Ursodeoxycholic acid improves pregnancy outcome in patients with intrahepatic cholestasis during pregnancy: A protocol for systematic review and meta-analysis.

Authors:  Yan Wang; Xiabiao Peng; Yongyuan Zhang; Qiuchen Yang; Yuhong Xiao; Yuezhou Chen
Journal:  Medicine (Baltimore)       Date:  2021-01-29       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.